{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:14:02Z","timestamp":1780582442525,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.lungcan.2023.107187","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T14:07:08Z","timestamp":1680703628000},"page":"107187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study"],"prefix":"10.1016","volume":"179","author":[{"given":"Claudia","family":"Sanjinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Botteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie C","family":"St\u00f8er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lukas L\u00f6fling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2023.107187_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.lungcan.2023.107187_b0010","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, Bonaventure A, Valkov M, Johnson CJ, Est\u00e8ve J, Ogunbiyi OJ, Azevedo e Silva G, Chen W-Q, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP, Bouzbid S, Hamdi-Ch\u00e9rif M, Zaidi Z, Meguenni K, Regagba D, Bayo S, Cheick Bougadari T, Manraj SS, Bendahhou K, Fabowale A, Bradshaw D, Somdyala NIM, Kumcher I, Moreno F, Calabrano GH, Espinola SB, Carballo Quintero B, Fita R, Diumenjo MC, Laspada WD, Iba\u00f1ez SG, Lima CA, De Souza PCF, Del Pino K, Laporte C, Curado MP, de Oliveira JC, Veneziano CLA, Veneziano DB, Latorre MRDO, Tanaka LF, Rebelo MS, Santos MO, Galaz JC, Aparicio Aravena M, Sanhueza Monsalve J, Herrmann DA, Vargas S, Herrera VM, Uribe CJ, Bravo LE, Garcia LS, Arias-Ortiz NE, Morantes D, Jurado DM, Y\u00e9pez Chamorro MC, Delgado S, Ramirez M, Gal\u00e1n Alvarez YH, Torres P, Mart\u00ednez-Reyes F, Jaramillo L, Quinto R, Castillo J, Mendoza M, Cueva P, Y\u00e9pez JG, Bhakkan B, Deloumeaux J, Joachim C, Macni J, Carrillo R, Shalkow Klincovstein J, Rivera Gomez R, Poquioma E, Tortolero-Luna G, Zavala D, Alonso R, Barrios E, Eckstrand A, Nikiforuk C, Noonan G, Turner D, Kumar E, Zhang B, McCrate FR, Ryan S, MacIntyre M, Saint-Jacques N, Nishri DE, McClure CA, Vriends KA, Kozie S, Stuart-Panko H, Freeman T, George JT, Brockhouse JT, O'Brien DK, Holt A, Almon L, Kwong S, Morris C, Rycroft R, Mueller L, Phillips CE, Brown H, Cromartie B, Schwartz AG, Vigneau F, Levin GM, Wohler B, Bayakly R, Ward KC, Gomez SL, McKinley M, Cress R, Green MD, Miyagi K, Ruppert LP, Lynch CF, Huang B, Tucker TC, Deapen D, Liu L, Hsieh MC, Wu XC, Schwenn M, Gershman ST, Knowlton RC, Alverson G, Copeland GE, Bushhouse S, Rogers DB, Jackson-Thompson J, Lemons D, Zimmerman HJ, Hood M, Roberts-Johnson J, Rees JR, Riddle B, Pawlish KS, Stroup A, Key C, Wiggins C, Kahn AR, Schymura MJ, Radhakrishnan S, Rao C, Giljahn LK, Slocumb RM, Espinoza RE, Khan F, Aird KG, Beran T, Rubertone JJ, Slack SJ, Garcia L, Rousseau DL, Janes TA, Schwartz SM, Bolick SW, Hurley DM, Whiteside MA, Miller-Gianturco P, Williams MA, Herget K, Sweeney C, Johnson AT, Keitheri Cheteri MB, Migliore Santiago P, Blankenship SE, Farley S, Borchers R, Malicki R, Espinoza JR, Grandpre J, Wilson R, Edwards BK, Mariotto A, Lei Y, Wang N, Chen JS, Zhou Y, He YT, Song GH, Gu XP, Mei D, Mu HJ, Ge HM, Wu TH, Li YY, Zhao DL, Jin F, Zhang JH, Zhu FD, Junhua Q, Yang YL, Jiang CX, Biao W, Wang J, Li QL, Yi H, Zhou X, Dong J, Li W, Fu FX, Liu SZ, Chen JG, Zhu J, Li YH, Lu YQ, Fan M, Huang SQ, Guo GP, Zhaolai H, Wei K, Zeng H, Demetriou AV, Mang WK, Ngan KC, Kataki AC, Krishnatreya M, Jayalekshmi PA, Sebastian P, Nandakumar A, Malekzadeh R, Roshandel G, Keinan-Boker L, Silverman BG, Ito H, Nakagawa H, Sato M, Tobori F, Nakata I, Teramoto N, Hattori M, Kaizaki Y, Moki F, Sugiyama H, Utada M, Nishimura M, Yoshida K, Kurosawa K, Nemoto Y, Narimatsu H, Sakaguchi M, Kanemura S, Naito M, Narisawa R, Miyashiro I, Nakata K, Sato S, Yoshii M, Oki I, Fukushima N, Shibata A, Iwasa K, Ono C, Nimri O, Jung KW, Won YJ, Alawadhi E, Elbasmi A, Ab Manan A, Adam F, Sanjaajmats E, Tudev U, Ochir C, Al Khater AM, El Mistiri MM, Teo YY, Chiang CJ, Lee WC, Buasom R, Sangrajrang S, Kamsa-ard S, Wiangnon S, Daoprasert K, Pongnikorn D, Leklob A, Sangkitipaiboon S, Geater SL, Sriplung H, Ceylan O, K\u00f6g I, Dirican O, K\u00f6se T, Gurbuz T, Kara\u015fahin FE, Turhan D, Akta\u015f U, Halat Y, Yakut CI, Altinisik M, Cavusoglu Y, T\u00fcrkk\u00f6yl\u00fc A, \u00dc\u00e7\u00fcnc\u00fc N, Hackl M, Zborovskaya AA, Aleinikova OV, Henau K, Van Eycken L, Valerianova Z, Yordanova MR, \u0160ekerija M, Du\u0161ek L, Zvolsk\u00fd M, Storm H, Innos K, M\u00e4gi M, Malila N, Sepp\u00e4 K, J\u00e9gu J, Velten M, Cornet E, Troussard X, Bouvier AM, Guizard AV, Bouvier V, Launoy G, Arveux P, Maynadi\u00e9 M, Mounier M, Woronoff AS, Daoulas M, Robaszkiewicz M, Clavel J, Goujon S, Lacour B, Baldi I, Pouchieu C, Amadeo B, Coureau G, Orazio S, Preux PM, Rharbaoui F, Marrer E, Tr\u00e9tarre B, Colonna M, Delafosse P, Ligier K, Plouvier S, Cowppli-Bony A, Molini\u00e9 F, Bara S, Ganry O, Lap\u00f4tre-Ledoux B, Grosclaude P, Bossard N, Uhry Z, Bray F, Pi\u00f1eros M, Stabenow R, Wilsdorf-K\u00f6hler H, Eberle A, Luttmann S, L\u00f6hden I, Nennecke AL, Kieschke J, Sirri E, Emrich K, Zeissig SR, Holleczek B, Eisemann N, Katalinic A, Asquez RA, Kumar V, Petridou E, \u00d3lafsd\u00f3ttir EJ, Tryggvad\u00f3ttir L, Clough-Gorr K, Walsh PM, Sundseth H, Mazzoleni G, Vittadello F, Coviello E, Cuccaro F, Galasso R, Sampietro G, Giacomin A, Magoni M, Ardizzone A, D'Argenzio A, Castaing M, Grosso G, Lavecchia AM, Sutera Sardo A, Gola G, Gatti L, Ricci P, Ferretti S, Serraino D, Zucchetto A, Celesia MV, Filiberti RA, Pannozzo F, Melcarne A, Quarta F, Russo AG, Carrozzi G, Cirilli C, Cavalieri d'Oro L, Rognoni M, Fusco M, Vitale MF, Usala M, Cusimano R, Mazzucco W, Michiara M, Sgargi P, Boschetti L, Borciani E, Seghini P, Maule MM, Merletti F, Tumino R, Mancuso P, Vicentini M, Cassetti T, Sassatelli R, Falcini F, Giorgetti S, Caiazzo AL, Cavallo R, Cesaraccio R, Pirino DR, Contrino ML, Tisano F, Fanetti AC, Maspero S, Carone S, Mincuzzi A, Candela G, Scuderi T, Gentilini MA, Piffer S, Rosso S, Barchielli A, Caldarella A, Bianconi F, Stracci F, Contiero P, Tagliabue G, Rugge M, Zorzi M, Beggiato S, Brustolin A, Berrino F, Gatta G, Sant M, Buzzoni C, Mangone L, Capocaccia R, De Angelis R, Zanetti R, Maurina A, Pildava S, Lipunova N, Vincer\u017eevskien\u00e9 I, Agius D, Calleja N, Siesling S, Lar\u00f8nningen S, M\u00f8ller B, Dyzmann-Sroka A, Trojanowski M, G\u00f3\u017ad\u017a S, M\u0119\u017cyk R, Mierzwa T, Molong L, Rachtan J, Szewczyk S, B\u0142aszczyk J, K\u0119pska K, Ko\u015bcia\u0144ska B, Taroci\u0144ska K, Zwierko M, Drosik K, Maksimowicz KM, Purwin-Porowska E, Reca E, W\u00f3jcik-Tomaszewska J, Tukiendorf A, Gr\u0105dalska-Lampart M, Radziszewska AU, Gos A, Talerczyk M, Wyborska M, Didkowska JA, Wojciechowska U, Bielska-Lasota M, Forjaz de Lacerda G, Rego RA, Bastos J, Silva MA, Antunes L, Laranja Pontes J, Mayer-da-Silva A, Miranda A, Blaga LM, Coza D, Gusenkova L, Lazarevich O, Prudnikova O, Vjushkov DM, Egorova AG, Orlov AE, Kudyakov LA, Pikalova LV, Adamcik J, Safaei Diba C, Primic-\u017dakelj M, Zadnik V, Larra\u00f1aga N, Lopez de Munain A, Herrera AA, Redondas R, Marcos-Gragera R, Vilardell Gil ML, Molina E, S\u00e1nchez Perez MJ, Franch Sureda P, Ramos Montserrat M, Chirlaque MD, Navarro C, Ardanaz EE, Guevara MM, Fern\u00e1ndez-Delgado R, Peris-Bonet R, Carulla M, Galceran J, Alberich C, Vicente-Raneda M, Khan S, Pettersson D, Dickman P, Avelina I, Staehelin K, Camey B, Bouchardy C, Schaffar R, Frick H, Herrmann C, Bulliard JL, Maspoli-Conconi M, Kuehni CE, Redmond SM, Bordoni A, Ortelli L, Chiolero A, Konzelmann I, Matthes KL, Rohrmann S, Broggio J, Rashbass J, Fitzpatrick D, Gavin A, Clark DI, Deas AJ, Huws DW, White C, Montel L, Rachet B, Turculet AD, Stephens R, Chalker E, Phung H, Walton R, You H, Guthridge S, Johnson F, Gordon P, D'Onise K, Priest K, Stokes BC, Venn A, Farrugia H, Thursfield V, Dowling J, Currow D, Hendrix J, Lewis C. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018;391(10125):1023-75. doi:10.1016\/S0140-6736(17)33326-3."},{"key":"10.1016\/j.lungcan.2023.107187_b0015","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29(Suppl 4):iv192-iv237","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2023.107187_b0020","first-page":"2322","volume":"14","author":"Calaf","year":"2022","journal-title":"Muscarinic Receptors Associated with Cancer. Cancers."},{"issue":"24\u201325","key":"10.1016\/j.lungcan.2023.107187_b0025","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.lfs.2006.12.017","article-title":"Role of non-neuronal cholinergic system in breast cancer progression","volume":"80","author":"Espanol","year":"2007","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.lungcan.2023.107187_b0030","first-page":"2532","article-title":"Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor","volume":"5","author":"Frucht","year":"1999","journal-title":"Clin Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107187_b0035","first-page":"214","article-title":"Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma","volume":"63","author":"Song","year":"2003","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2023.107187_b0040","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1158\/0008-5472.CAN-06-2484","article-title":"M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion","volume":"67","author":"Song","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2023.107187_b0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-3-642-23274-9_19","article-title":"Muscarinic receptor agonists and antagonists: effects on cancer","volume":"208","author":"Spindel","year":"2012","journal-title":"Handb Exp Pharmacol."},{"issue":"6","key":"10.1016\/j.lungcan.2023.107187_b0050","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1007\/s13277-014-2911-z","article-title":"Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR\/PI3K\/AKT pathway","volume":"36","author":"Xu","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lungcan.2023.107187_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.12965","article-title":"Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study","author":"Hallas","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"10.1016\/j.lungcan.2023.107187_b0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CLEP.S186842","article-title":"Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer","volume":"11","author":"L\u00f6fling","year":"2019","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107187_b0065","doi-asserted-by":"crossref","DOI":"10.5324\/nje.v18i2.23","article-title":"Establishment of the nationwide Norwegian Prescription Database (NorPD) \u2013 new opportunities for research in pharmacoepidemiology in Norway","volume":"18","author":"Furu","year":"2009","journal-title":"Norsk Epidemiologi."},{"key":"10.1016\/j.lungcan.2023.107187_b0070","unstructured":"Norwegian Institute of Public Health. Norwegian Cause of Death Registry. https:\/\/www.fhi.no\/hn\/helseregistre-og-registre\/dodsarsaksregisteret\/dodsarsaksregisteret2\/. Accessed 2022-11-22."},{"key":"10.1016\/j.lungcan.2023.107187_b0075","unstructured":"Statistics Norway. https:\/\/www.ssb.no\/en. Accessed 2022-11-22."},{"key":"10.1016\/j.lungcan.2023.107187_b0080","doi-asserted-by":"crossref","unstructured":"Hofvind S, Robsahm TE, Sagstad S, Thy JE. Sociodemographic factors, health indicators and lifestyle factors among participants in BreastScreen Norway 2006-2016 \u2013 a cohort profile. Norsk Epidemiologi. 2022;30(1-2). doi:10.5324\/nje.v30i1-2.4980.","DOI":"10.5324\/nje.v30i1-2.4980"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107187_b0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ije\/dym217","article-title":"Cohort Profile: Cohort of Norway (CONOR)","volume":"37","author":"N\u00e6ss","year":"2007","journal-title":"Int J Epidemiol."},{"issue":"4","key":"10.1016\/j.lungcan.2023.107187_b0090","first-page":"1101","article-title":"Cohort Profile Update: The Janus Serum Bank Cohort in Norway","volume":"46","author":"Hjerkind","year":"2017","journal-title":"Int J Epidemiol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107187_b0095","first-page":"55","article-title":"The, \u201cRoms\u00e5s in Motion\u201d study: Promoting physical activity in multi-ethnic district","volume":"13","author":"Jenum","year":"2003","journal-title":"Norsk Epidemiologi."},{"key":"10.1016\/j.lungcan.2023.107187_b0100","unstructured":"Norwegian Tax Agency. Personal Identification Number. https:\/\/www.skatteetaten.no\/en\/person\/foreign\/norwegian-identification-number\/what-is-an-identification-number\/. Accessed 2022-11-22."},{"key":"10.1016\/j.lungcan.2023.107187_b0105","unstructured":"Cancer Registry of Norway. Cancer in Norway 2020 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo, Norway. 2021. https:\/\/www.kreftregisteret.no\/globalassets\/cancer-in-norway\/2020\/cin-2020.pdf. Accessed 2022-04-20."},{"issue":"7","key":"10.1016\/j.lungcan.2023.107187_b0110","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","article-title":"Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness","volume":"45","author":"Larsen","year":"2009","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.lungcan.2023.107187_b0115","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. https:\/\/seer.cancer.gov\/. Accessed 2022-11-22."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107187_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal Diagrams for Epidemiologic Research","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiol."},{"key":"10.1016\/j.lungcan.2023.107187_b0125","article-title":"Repurposing antimuscarinics to treat lethal chemoresistant prostate and lung cancers","volume":"38(15_suppl):e15636-e","author":"Bland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2023.107187_b0130","doi-asserted-by":"crossref","unstructured":"Fr\u00fch M, De Ruysscher D, Popat S, Crin\u00f2 L, Peters S, Felip E, on behalf of the EGWG. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Annals of Oncology. 2013;24(suppl_6):vi99-vi105. doi:10.1093\/annonc\/mdt178.","DOI":"10.1093\/annonc\/mdt178"},{"key":"10.1016\/j.lungcan.2023.107187_b0135","doi-asserted-by":"crossref","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S, on behalf of the EGC. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Annals of Oncology. 2017;28(suppl_4):iv1-iv21. doi:10.1093\/annonc\/mdx222.","DOI":"10.1093\/annonc\/mdx222"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107187_b0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12913-016-1952-y","article-title":"Medical complexity and time to lung cancer treatment \u2013 a three-year retrospective chart review","volume":"17","author":"Stokstad","year":"2017","journal-title":"BMC Health Serv. Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223007250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223007250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:05:42Z","timestamp":1759237542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500223007250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"alternative-id":["S0169500223007250"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107187","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107187"}}